SB
Sean Brynjelsen
President & CEODirector

Sean Brynjelsen insider trades: Eton Pharmaceuticals (ETON) stock buys and sales

President & CEO, Eton Pharmaceuticals Last trade Aug 20, 2026 23 Form 4 filings
$9.9M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2018
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sean reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 20, 2026ETON↓ Sell$6.1M
May 28, 2026ETON↓ Sell$3.8M
Jun 5, 2025ETON↓ Sell$3.6M
Sep 22, 2022ETON↑ Buy$21K
Aug 20, 2021ETON↑ Buy$43K
Jun 3, 2021ETON↑ Buy$30K
Aug 13, 2019ETON↑ Buy$31K
May 21, 2019ETON↑ Buy$79K
Nov 15, 2018ETON↑ Buy$60K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ETON insiders

Open-market trades in the last 12 months

About Sean Brynjelsen's insider trades

Sean Brynjelsen is President & CEO at Eton Pharmaceuticals (ETON). Since Nov 15, 2018, Sean has reported 6 open-market purchases worth $264K and 3 sales worth $13.5M on SEC Form 4. In the last 12 months: 2 sales ($9.9M).

Their filings also include grants and awards (11 filings), shares withheld for taxes (2 filings), option exercises (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.